The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents
dc.contributor.author | Banks, Matthew L. | |
dc.contributor.author | Worst, Travis J. | |
dc.contributor.author | Rusyniak, Daniel E. | |
dc.contributor.author | Sprague, Jon E. | |
dc.contributor.department | Emergency Medicine, School of Medicine | en_US |
dc.date.accessioned | 2018-05-25T13:36:32Z | |
dc.date.available | 2018-05-25T13:36:32Z | |
dc.date.issued | 2015-12 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Banks, M. L., Worst, T. J., Rusyniak, D. E., & Sprague, J. E. (2015). The α- and β-adrenergic antagonist controversy with sympathomimetic agents. The Journal of Emergency Medicine, 49(6), e209–e210. http://doi.org/10.1016/j.jemermed.2015.06.004 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/16257 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.jemermed.2015.06.004 | en_US |
dc.relation.journal | The Journal of Emergency Medicine | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Alkaloids | en_US |
dc.subject | Central nervous system stimulants | en_US |
dc.subject | Designer drugs | en_US |
dc.subject | Psychotropic drugs | en_US |
dc.subject | Substance-related disorders | en_US |
dc.title | The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents | en_US |
dc.type | Article | en_US |